• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

BioGaia

121.30 SEK

-0.57 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.57 %
-1.62 %
+3.76 %
+15.52 %
+14.22 %
+14.76 %
+4.57 %
+23.65 %
+1,607.65 %

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Read more
Market cap
12.27B SEK
Turnover
2.48M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
17.7.
2026

Interim report Q2'26

22.10.
2026

Interim report Q3'26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

BioGaia, Audiocast, Q2'26
Webcast17.07.2026 klo 10.30

BioGaia, Audiocast, Q2'26

BioGaia
Regulatory press release07.05.2026 klo 19.00

Bulletin from Annual General Meeting of BioGaia AB (publ)

BioGaia
BioGaia, Audiocast, Q1'26
Webcast07.05.2026 klo 10.30

BioGaia, Audiocast, Q1'26

BioGaia

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release07.05.2026 klo 09.00

BioGaia AB: Interim Management Statement January - March 2026

BioGaia
Regulatory press release30.03.2026 klo 16.00

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia
Regulatory press release30.03.2026 klo 12.00

BioGaia Annual and Sustainability Report 2025 published

BioGaia
Press release17.03.2026 klo 14.00

BioGaia exercises option to acquire remaining shares in Nutraceutics

BioGaia
BioGaia, Audiocast, Q4'25
Webcast12.02.2026 klo 10.30

BioGaia, Audiocast, Q4'25

BioGaia
Regulatory press release12.02.2026 klo 09.00

BioGaia AB: Year-end report January - December 2025

BioGaia
Regulatory press release03.02.2026 klo 09.00

BioGaia's results for the fourth quarter to exceed market expectations

BioGaia
BioGaia, Audiocast, Q3'25
Webcast22.10.2025 klo 10.30

BioGaia, Audiocast, Q3'25

BioGaia
Regulatory press release22.10.2025 klo 09.00

BioGaia AB: Interim Management Statement January - September 2025

BioGaia
Regulatory press release22.08.2025 klo 18.30

Extraordinary General Meeting of BioGaia

BioGaia
Regulatory press release25.07.2025 klo 10.30

Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)

BioGaia
BioGaia, Audiocast, Q2'25
Webcast18.07.2025 klo 10.30

BioGaia, Audiocast, Q2'25

BioGaia
Regulatory press release18.07.2025 klo 09.00

BioGaia AB: Interim Report January - June 2025

BioGaia
Press release16.07.2025 klo 11.00

BioGaia AB launches a subsidiary company - BioGaia New Sciences AB - dedicated to advancing microbiome research and innovation

BioGaia
Regulatory press release30.05.2025 klo 12.00

Change in the number of votes in BioGaia AB (publ)

BioGaia
Regulatory press release07.05.2025 klo 19.30

Annual General Meeting of BioGaia

BioGaia
BioGaia, Audiocast, Q1'25
Webcast07.05.2025 klo 10.30

BioGaia, Audiocast, Q1'25

BioGaia